Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Ca.O |
| Molecular Weight | 56.077 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[Ca++]
InChI
InChIKey=BRPQOXSCLDDYGP-UHFFFAOYSA-N
InChI=1S/Ca.O/q+2;-2
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Ca |
| Molecular Weight | 40.078 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24604256http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticarieCurator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24604256http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticarie
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Olaflur (amine fluoride 297, trade name elmex gel) is a fluoride-containing substance that is an ingredient of toothpastes and solutions for the prevention of dental caries. Especially in combination with dectaflur, it is also used in the form of gels for the treatment of early stages of caries, sensitive teeth, and by dentists for the refluoridation of damaged tooth enamel. Olaflur is a salt consisting of an alkyl ammonium cation and fluoride as the counterion. With a long lipophilic hydrocarbon chain, the cation has surfactant properties. It forms a film layer on the surface of teeth, which facilitates incorporation of fluoride into the enamel. The top layers of the enamel's primary mineral, hydroxylapatite, are converted into the more robust fluorapatite. The fluoridation reaches only a depth of a few nanometres, which has raised doubts whether the mechanism really relies on the formation of fluorapatite.
CNS Activity
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Allergic contact cheilitis caused by olaflur in toothpaste. | 2017-01 |
|
| Cytotoxicity of organic surface coating agents used for nanoparticles synthesis and stability. | 2015-06 |
|
| Oleylamine as a beneficial agent for the synthesis of CoFe₂O₄ nanoparticles with potential biomedical uses. | 2014-05-07 |
|
| Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. | 2013-01 |
|
| Successful extracorporeal life support after potentially fatal pulmonary oedema caused by inhalation of nitric and hydrofluoric acid fumes. | 2007-10 |
|
| Epidemiology of 377 patients with chemical burns in Guangdong province. | 2004-09 |
|
| An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes. | 2004-08 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6936207
toxicity in mice: LD50 = 888 mg/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25746383
Cytotoxicity study: it was explored the cytotoxicity of the coating agent, Oleylamine in two cell lines, human epidermal keratinocyte (HaCaT) and lung fibroblast (CRL-1490) cells, at surface coating agent concentrations of 3, 10, 30, and 100 μM. Two exposure time points, 2 h, and 24 h were employed for the study. Oleylamine, is highly toxic, leading to almost 100% cell death.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:31 GMT 2025
by
admin
on
Mon Mar 31 18:31:31 GMT 2025
|
| Record UNII |
C7X2M0VVNH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 184.1210
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
WHO-VATC |
QP53AX18
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
DSLD |
260 (Number of products:101)
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
NCI_THESAURUS |
C42634
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
EPA PESTICIDE CODE |
75604
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-529
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
||
|
JECFA EVALUATION |
INS-529
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C016538
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
CALCIUM OXIDE
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
DTXSID5029631
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
31344
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
C82641
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
m2958
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
6850728
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
1615
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
51486
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
100000092621
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
C7X2M0VVNH
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
DB15648
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
1305-78-8
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
215-138-9
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
C7X2M0VVNH
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104397
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
SUB13189MIG
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
SUB29992
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | |||
|
28728
Created by
admin on Mon Mar 31 18:31:31 GMT 2025 , Edited by admin on Mon Mar 31 18:31:31 GMT 2025
|
PRIMARY | RxNorm |